Clinical study on preimplantation genetic diagnosis on balanced reciprocal transorocation (CT-28)
Not Applicable
- Conditions
- recurrent pregnancy loss
- Registration Number
- JPRN-UMIN000018046
- Lead Sponsor
- Keio University school of medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 1
Inclusion Criteria
Not provided
Exclusion Criteria
nothing paticulary
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method diagnostic efficacy of PGD
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie PGD success rates in balanced reciprocal translocation carriers with recurrent pregnancy loss?
How does preimplantation genetic diagnosis for balanced reciprocal translocation compare to standard prenatal screening in preventing chromosomal abnormalities?
Which biomarkers are most predictive of successful embryo selection in PGD for balanced reciprocal translocation (CT-28) cases?
What are the potential adverse events associated with PGD procedures in patients with recurrent pregnancy loss and how are they managed?
Are there combination approaches or alternative therapies being explored alongside PGD for balanced reciprocal translocation to improve live birth rates in recurrent pregnancy loss patients?